Anti-human IL21 monoclonal antibody, avizakimab biosimilar (BOS161721)

Home/ Products / Biosimilar Antibodies

PRODUCT

  • SKU

    DMS1107-100ug

  • Size

    100 ug

  • Price

    $350

1
This monoclonal antibody is part of a collection of biosimilar antibodies in reference to those approved or in clinical investigation. The biosimilars are for Research Use Only and should not be used in therapeutic or diagnostic procedures in humans or animals.
target IL21
alias CVID11, Za11
gene id Uniprote ID: Q9HBE4
host species Humanized
reactivity Human
iso type IgG1
formulation Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization.
reconstitution Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage.
applications ELISA
dilution ELISA 1:5000-10000
shipping Shipped at ambient conditions.
storage Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months.
note Other commonly used names in publications refering to this antibody: BOS161721

Images

ELISA plate coated with 2 ug/mL (100 uL/well) Human IL21 Protein, hFc Tag binds to anti-IL21 neutralizing antibody in a linear range of 2.44?156.25 ng/mL.


PRODUCT

  • SKU

    DMS1107-100ug

  • Size

    100 ug

  • Price

    $350

1